Abel Hall, LLC

SEC CIK: 0002013339
Latest filing: Jul 24, 2026

SEC filings (opens in a new tab)

IKT holding history

Inhibikase Therapeutics, Inc. in every 13F filed by Abel Hall, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

IKT overview All 13F holders of IKT Full Q2 2026 holdings

Shares (Q2 2026): 46,352
Value: $94.1K
% of portfolio: <0.1%
Quarters held: 2; Since Q1 2026

Holdings of IKT by Abel Hall, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	46,352	$94.1K	<0.1%	+31,789+218.3%	Added	Holders
Q1 2026	14,563	$24.5K	<0.1%	+14,563	New	Holders